| WHO classification of tumours of haematopoietic and lymphoid tissues E Campo, NL Harris, ES Jaffe, SA Pileri, H Stein, J Thiele, JW Vardiman International agency for research on cancer 2, 439, 2008 | 23405* | 2008 |
| Diagnostic criteria and classification of mastocytosis: a consensus proposal P Valent, HP Horny, L Escribano, BJ Longley, CY Li, LB Schwartz, ... Leukemia research 25 (7), 603-625, 2001 | 1331 | 2001 |
| Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria P Valent, C Akin, L Escribano, M Födinger, K Hartmann, K Brockow, ... European journal of clinical investigation 37 (6), 435-453, 2007 | 896 | 2007 |
| Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal P Valent, C Akin, M Arock, K Brockow, JH Butterfield, MC Carter, ... International archives of allergy and immunology 157 (3), 215-225, 2012 | 683 | 2012 |
| KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA … AC Garcia-Montero, M Jara-Acevedo, C Teodosio, ML Sanchez, R Nunez, ... Blood 108 (7), 2366-2372, 2006 | 575 | 2006 |
| Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma … K Hartmann, L Escribano, C Grattan, K Brockow, MC Carter, ... Journal of Allergy and Clinical Immunology 137 (1), 35-45, 2016 | 419 | 2016 |
| Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients L Escribano, I Álvarez-Twose, L Sánchez-Muñoz, A Garcia-Montero, ... Journal of allergy and clinical immunology 124 (3), 514-521, 2009 | 312 | 2009 |
| Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and … M Ocqueteau, A Orfao, J Almeida, J Bladé, M Gonzalez, R García-Sanz, ... The American journal of pathology 152 (6), 1655, 1998 | 309 | 1998 |
| Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications L Escribano, A Orfao, B Dıaz-Agustin, J Villarrubia, C Cerveró, A López, ... Blood, The Journal of the American Society of Hematology 91 (8), 2731-2736, 1998 | 285 | 1998 |
| Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations M Castells, DD Metcalfe, L Escribano American journal of clinical dermatology 12, 259-270, 2011 | 280 | 2011 |
| KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis M Arock, K Sotlar, C Akin, S Broesby-Olsen, G Hoermann, L Escribano, ... Leukemia 29 (6), 1223-1232, 2015 | 278 | 2015 |
| Recent advances in the understanding of mastocytosis: the role of KIT mutations* A Orfao, AC Garcia‐Montero, L Sanchez, L Escribano British journal of haematology 138 (1), 12-30, 2007 | 277 | 2007 |
| Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria P Valent, C Akin, WR Sperr, L Escribano, M Arock, HP Horny, JM Bennett, ... Leukemia research 27 (7), 635-641, 2003 | 277 | 2003 |
| Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms I Álvarez-Twose, DG de Olano, L Sánchez-Muñoz, A Matito, ... Journal of allergy and clinical immunology 125 (6), 1269-1278. e2, 2010 | 276 | 2010 |
| Mastocytosis: current concepts in diagnosis and treatment L Escribano, C Akin, M Castells, A Orfao, D Metcalfe Annals of hematology 81, 677-690, 2002 | 276 | 2002 |
| Advances in the classification and treatment of mastocytosis: current status and outlook toward the future P Valent, C Akin, K Hartmann, G Nilsson, A Reiter, O Hermine, K Sotlar, ... Cancer research 77 (6), 1261-1270, 2017 | 272 | 2017 |
| Mastocytosis: pathology, genetics, and current options for therapy P Valent, C Akin, W Sperr, M Mayerhofer, M Födinger, R Fritsche-Polanz, ... Leukemia & lymphoma 46 (1), 35-48, 2005 | 269 | 2005 |
| Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease WR Sperr, JH Jordan, M Fiegl, L Escribano, C Bellas, S Dirnhofer, ... International archives of allergy and immunology 128 (2), 136-141, 2002 | 247 | 2002 |
| Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis WR Sperr, L Escribano, JH Jordan, GH Schernthaner, M Kundi, HP Horny, ... Leukemia research 25 (7), 529-536, 2001 | 239 | 2001 |
| One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes K Sotlar, L Escribano, O Landt, S Möhrle, S Herrero, A Torrelo, U Lass, ... The American journal of pathology 162 (3), 737-746, 2003 | 230 | 2003 |
José Mário MorgadoInstituto de Estudios de Mastocitosis de Castilla la ManchaDirección de correo verificada de sescam.jccm.es
